We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Processing Genomic Sequences in Minutes

By Biotechdaily staff writers
Posted on 07 Jul 2005
A new computational tool can divide the work of analyzing biologic data into manageable fragments, so that large data sets can run on many processors simultaneously, solving large-scale problems in minutes, rather than weeks.

Called ScalaBLAST, the tool was developed at the U.S. More...
Department of Energy's Pacific Northwest National Laboratory (PNNL, Richland, WA, USA; www.pnl.gov). PNNL's supercomputer has 1,960 processors, lots of memory, and the ability to tackle large problems. However, without special modifications, software does not run any faster on this computer than it would on a personal computer. In order to speed it up and get answers to complicated biologic questions more quickly, PNNL researchers "parallelized” the software, using Global Arrays, a powerful programming toolkit, by creating algorithms to divide up the work.

PNNL researchers state that ScalaBLAST may be used to process complex genomic sequences, essential to understanding the building blocks of the genome. Now they can manage the large influx of data resulting from new questions that arise during human genome research. Prior to this tool, it took researchers 10 days to analyze one organism. Now, they can analyze 13 organisms within nine hours, making the time-to-solution hundreds of times faster.

"Access to and understanding the pieces of genome sequences will allow researchers to understand the body's cellular machinery and discover clues to some types of cancer,” observed T.P. Straatsma, a PNNL senior research scientist. "And it will help in developing drugs or detection methods to be used for particular diseases.”






Related Links:
PNNL

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Clinical Informatics Platform
CLARION™
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.